China Medical University transfers Changsheng Biotechnology, cell therapy opens new dawn for cancer friends
China Medical University Hospital have collaborated with Ever Supreme in "GLORIA Advanced Biotechnology Medical International Industry-Academic Alliance" with technology transfer on the relevant dendritic cell therapy technology (ADCV01 ) from China Medical University for continual research and application in treatment on 8 types of solid cancers with autologous dendritic cells (DC), including: glioblastoma multiforme and secondary brain tumors, epithelial ovarian cancer, pancreatic cancer, and Guardian cancer, head and neck cancer, liver cancer, breast cancer and colorectal cancer. Ever Supreme will continue to work together with partners for next medical breakthrough, and help Taiwan's biotech industry as a driven force, and offer innovative, effective, and precise personal medical services, and move towards a new era for precision personalized medicine.